Pain is frequently reported during cancer disease, and it still remains poorly controlled in
40% of patients. Recent developments in oncology have helped to better control pain …

Abstract Purpose of Review Chemotherapy-induced peripheral neuropathy (CIPN) is a
debilitating and often painful condition that occurs after administration of chemotherapeutic …

Progress in the development of effective chemotherapy is producing a growing population of
patients with acute and chronic painful chemotherapy-induced peripheral neuropathy …

Gastrointestinal (GI) cancer is a formidable malignancy with significant morbidity and
mortality rates. Recent studies have shed light on the complex interplay between the …

Background Chronic intractable pain from peripheral neuropathy is a debilitating condition
that might not respond to conventional medical management and pharmacotherapy. The …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common, sometimes dose-
limiting side effect of neurotoxic chemotherapy. Treatment is limited because its …

Abstract Purpose of Review This review aims to discuss pathophysiology, diagnosis, clinical
presentation, and treatment of chemotherapy-induced peripheral neuropathy. Agent-specific …

Pain is an important innate defense mechanism that can dramatically alter a person's quality
of life. Understanding the microbiological and physiological effects of pain may be important …

Background Chemotherapy‐induced peripheral neuropathy (CIPN) is a common
consequence of cancer treatment that can be persistent and difficult to manage. Dorsal root …

Purpose To summarizes the available evidence on the effectiveness, safety, and feasibility
of complementary and alternative medicine (CAM) in the management of chemotherapy …